Гефтесса - analogs
Components: Gefitinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors || Antitumor drugs other |
|||||||||
| Prices in pharmacies: — Instructions Гефтесса | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Paracetamol ✘ (incl) Apixaban ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Iressa | 1114€ |
| ≈100% | neutral Gefitinib | — |
| ≈100% | neutral Gefitinib-TL | — |
| ≈100% | neutral Gefitinib-nativ | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 31% 190.2-195.7€ Зенлистик neutral [Abemaciclib]
- 27% 862.9€ Vargatef neutral [Nintedanib]
- 26% 291.9-1935.3€ Inlyta neutral [Axitinib]
- 26% — Ириноплат Negative 🔍 [Carboplatin]
- 25% — Carboplatin- BM Negative 🔍 [Carboplatin]
- 24% 1768-1810.3€ Stivarga neutral [Regorafenib]
- 23% 363.3-1164.9€ Afinitor neutral [Everolimus and more 1Butylated hydroxytoluene]
- 22% 1732.5€ Lenvima neutral [Lenvatinib]
- 21% — Сорафениб-натив neutral [Sorafenib]
- 21% — Сорафениб-промомед neutral [Sorafenib]
- 21% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 21% — Флутриксан neutral [Sorafenib]
- 21% — Erlotinib neutral [Erlotinib]
- 21% — Сорафениба тозилат neutral [Sorafenib]
- 21% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 21% 830-1485.8€ Nexavar neutral [Sorafenib]
- 21% 4850€ Imbruvica neutral [Ibrutinib]
- 21% — Eldisine Negative 🔍 [Vindesine]
- 21% — Paraplatin Negative 🔍 [Carboplatin]
- 21% 1645€ Cyramza Negative 🔍 [Ramucirumab]
- 20% 9.3€ Carboplatin-Teva Negative 🔍 [Carboplatin]
- 20% — Cycloplatin Negative 🔍 [Carboplatin]
- 20% 28.5€ Topotecan Actavis Dangerous 🔍 [Topotecan]
- 20% 42.3-61€ Philachromin FS Dangerous 🔍 [Imatinib]
- 20% 86.8€ Hycamtin Dangerous 🔍 [Topotecan]
- 20% — Blastocarb Negative 🔍 [Carboplatin]
- 20% — Carboplatin-Ebewe Negative 🔍 [Carboplatin]
- 20% 22€ Carboplatin-LANS Negative 🔍 [Carboplatin]
- 20% 4-21.5€ Carboplatin Negative 🔍 [Carboplatin]
- 20% 1€ Paract Negative 🔍 [Carboplatin]
- 20% — Carbotera Negative 🔍 [Carboplatin]
- 20% 29.1€ Карбоплатин-РОНЦ Negative 🔍 [Carboplatin]
- 20% 9-23.1€ Kemocarb Negative 🔍 [Carboplatin]
- 19% — Farmorubicin Negative 🔍 [Epirubicin]
- 19% — Эпирубицин-РОНЦ Negative 🔍 [Epirubicin]
- 19% — Epilek Negative 🔍 [Epirubicin]
- 19% — Эпирубицин-Келун-Казфарм Negative 🔍 [Epirubicin]
- 19% — Epirubicin Negative 🔍 [Epirubicin]
- 19% 11.7€ Farmorubicin rapid dissolution Negative 🔍 [Epirubicin]
- 19% — Эпирубицин-Рус Negative 🔍 [Epirubicin]
- 19% — Албитиниб Dangerous 🔍 [Imatinib]
- 19% — Epirubicin hydrochloride Negative 🔍 [Epirubicin]
- 19% 79-86.8€ Natulan Dangerous 🔍 [Procarbazine]
- 19% — Imatinib Dangerous 🔍 [Imatinib]
- 19% 114.4-127.7€ Glivec Dangerous 🔍 [Imatinib]
- 19% — Иматиниб-Сигардис Dangerous 🔍 [Imatinib]
- 18% 5-7.2€ РАФАМИН neutral [Interferon gamma human recombinant]
- 18% 3.2€ Анаферон neutral [Interferon gamma human recombinant]
- 18% — Mitoxantron AWD 25 Dangerous 🔍 [Mitoxantrone]
- 18% — Антитела к гамма-интерферону человека аффинно очищенные neutral [Interferon gamma human recombinant]
Learn more about the selection of analogues
- The drug has «Гефтесса» 12 full analogs, the cheapest - Iressa (1114€); 51 analog by action, the most similar - Vargatef (862.9€).
- Medical online service has selected the best substitutes for Гефтесса based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Гефтесса to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.